Is there a halo-enzymopathy in Parkinson’s disease?
Laboratory studies identified changes in the metabolism of halogens in the serum and cerebrospinal fluid (CSF) of patients with Parkinson’s disease, which indicates the presence of “accelerated self-halogenation” of CSF and/or an increase in haloperoxidases, specifically serum thyroperoxidase and CS...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2022-10-01
|
| Series: | Neurología (English Edition) |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580821000195 |